AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nichi-Iko Pharmaceutical Co., Ltd.
  3. Financials
  4. Cash from financing

Nichi-Iko Pharmaceutical Co., Ltd.【JP:E00963】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 202219,677+81.07%
Mar 31, 202110,867+984.53%
Mar 31, 20201,002-95.96%
Mar 31, 201924,803+673.64%
Mar 31, 20183,206-95.04%
Mar 31, 201764,620+508.13%
Mar 31, 201610,626-175.12%
Mar 31, 2015-14,146

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)